Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
36.37
-1.44 (-3.81%)
At close: Jul 16, 2026, 4:00 PM EDT
36.11
-0.26 (-0.71%)
Pre-market: Jul 17, 2026, 4:30 AM EDT
Viking Therapeutics Employees
Viking Therapeutics had 59 employees as of March 31, 2026. The number of employees increased by 13 or 28.26% compared to the same quarter last year.
Employees
59
Change
13
Growth
28.26%
Revenue / Employee
n/a
Profits / Employee
-$8,005,678
Market Cap
4.22B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Caris Life Sciences | 1,846 |
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| CRISPR Therapeutics AG | 393 |
| Dyne Therapeutics | 263 |
| Relay Therapeutics | 193 |
| Catalyst Pharmaceuticals | 182 |
VKTX News
- 2 days ago - Viking Therapeutics Slides: Corporate presentation - Filings
- 7 days ago - Viking Therapeutics (VKTX) Price Forecast: Bottoming Pattern Signals Growing Strength - FXEmpire
- 22 days ago - Viking catalysts include VK3019, VK2735 readouts in Q3, says Raymond James - TheFly
- 22 days ago - Viking Therapeutics begins Phase 1 SAD clinical trial of VK3019 - TheFly
- 22 days ago - Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults - PRNewsWire
- 4 weeks ago - Viking Therapeutics management to meet with B. Riley - TheFly
- 5 weeks ago - Viking Therapeutics names Hubert Chen, M.D., as Chief Medical Officer - TheFly
- 5 weeks ago - Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D. - PRNewsWire